BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16630454)

  • 1. [Comparison of the effects of intravenous recombinant human brain natriuretic peptide and nitroglycerin in patients with decompensated acute heart failure: a multicenter, randomized, open-label, parallel-design study].
    Recombinant Human Brain Natriuretic Peptide Study Group
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Mar; 34(3):222-6. PubMed ID: 16630454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute hemodynamic effects of intravenous recombinant human brain natriuretic peptide in patients with acute myocardial infarction complicated with heart failure].
    Li SQ; Fu XH; Liu J; Gu XS; Zhang J; Fan XN; Jiang YF; Miao Q
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):23-7. PubMed ID: 16626544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic effect of recombinant human brain natriuretic peptide for treatment of decompensated heart failure: comparison with nitroglycerin].
    Xie CL; Meng SR; Wang W; Chen SM; Li P; Feng XG
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):839-42. PubMed ID: 18504215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy and safety of intravenous recombinant human brain natriuretic peptide in patients with decompensated acute heart failure: a multicenter, randomized, open label, controlled study].
    ; Hu DY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Apr; 39(4):305-8. PubMed ID: 21624304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of recombinant human B-type natriuretic peptide for the protection of cardiac and renal functions in heart failure patients with acute anterior myocardial infarction in peri-operative period of primary percutaneous coronary intervention].
    Zhang J; Fu XH; Fan XN; Jia XW; Gu XS; Li SQ; Jiang YF; Fan WZ; Su JL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Nov; 22(11):669-73. PubMed ID: 21122202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.
    Colucci WS; Elkayam U; Horton DP; Abraham WT; Bourge RC; Johnson AD; Wagoner LE; Givertz MM; Liang CS; Neibaur M; Haught WH; LeJemtel TH
    N Engl J Med; 2000 Jul; 343(4):246-53. PubMed ID: 10911006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of B-type brain natriuretic peptide on patients with acute decompensated heart failure coexisting with lung cancer: a randomized controlled clinical trial.
    Wang S; Qu X; Qu Y; Yu Y; Feng W
    Pharmazie; 2014 Mar; 69(3):212-6. PubMed ID: 24716412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized multicenter study comparing the efficacy and safety of intravenous milrinone and intravenous nitroglycerin in patients with advanced heart failure.
    Loh E; Elkayam U; Cody R; Bristow M; Jaski B; Colucci WS
    J Card Fail; 2001 Jun; 7(2):114-21. PubMed ID: 11420762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recombinant human brain natriuretic peptide on the cardiac hemodynamics and renal function in dogs with heart failure].
    Xu XW; Zeng GY; Yang Y; Liu HX
    Yao Xue Xue Bao; 2002 Oct; 37(10):758-62. PubMed ID: 12567856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.
    Burger AJ; Horton DP; LeJemtel T; Ghali JK; Torre G; Dennish G; Koren M; Dinerman J; Silver M; Cheng ML; Elkayam U;
    Am Heart J; 2002 Dec; 144(6):1102-8. PubMed ID: 12486437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with different blood BNP levels.
    Pan HY; Zhu JH; Gu Y; Yu XH; Pan M; Niu HY
    BMC Cardiovasc Disord; 2014 Mar; 14():31. PubMed ID: 24593826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
    Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF)
    JAMA; 2002 Mar; 287(12):1531-40. PubMed ID: 11911755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of pretreatment with recombinant human B-type natriuretic peptide on infarct size in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Li S; Fu X; Dai Y; Liu C; Wang Y; Li W; Wu W; Gu X; Hao G; Fan W; Miao Q; Jiang Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Nov; 43(11):954-9. PubMed ID: 26888806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of recombinant human brain natriuretic peptide on renal function in patients with acute heart failure following myocardial infarction.
    Wang Y; Gu X; Fan W; Fan Y; Li W; Fu X
    Am J Transl Res; 2016; 8(1):239-45. PubMed ID: 27069557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.
    Aronson D; Burger AJ
    Am Heart J; 2004 Nov; 148(5):e16. PubMed ID: 15523294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of recombinant human brain natriuretic peptide (rhBNP) versus nitroglycerin in patients with heart failure: A systematic review and meta-analysis.
    Zhang S; Wang Z
    Medicine (Baltimore); 2016 Nov; 95(44):e4757. PubMed ID: 27858837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database.
    Costanzo MR; Johannes RS; Pine M; Gupta V; Saltzberg M; Hay J; Yancy CW; Fonarow GC
    Am Heart J; 2007 Aug; 154(2):267-77. PubMed ID: 17643575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
    Abraham WT; Adams KF; Fonarow GC; Costanzo MR; Berkowitz RL; LeJemtel TH; Cheng ML; Wynne J; ;
    J Am Coll Cardiol; 2005 Jul; 46(1):57-64. PubMed ID: 15992636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal function and neurohormonal changes following intravenous infusions of nitroglycerin versus nesiritide in patients with acute decompensated heart failure.
    Chow SL; O'Barr SA; Peng J; Chew E; Pak F; Quist R; Patel P; Patterson JH; Heywood JT
    J Card Fail; 2011 Mar; 17(3):181-7. PubMed ID: 21362524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis.
    Levy P; Compton S; Welch R; Delgado G; Jennett A; Penugonda N; Dunne R; Zalenski R
    Ann Emerg Med; 2007 Aug; 50(2):144-52. PubMed ID: 17509731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.